Direxion Daily Healthcare Bull 3X ETF
CURE
4 hedge funds and large institutions have $3.97M invested in Direxion Daily Healthcare Bull 3X ETF in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.
582% more capital inflows, than outflows
Capital inflows: $2.08M | Capital outflows: $305K
33% more funds holding
Funds holding: 3 → 4 (+1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.04M |
| 2 |
Wilbanks Smith & Thomas Asset Management
Norfolk,
Virginia
|
+$1.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS
Zurich,
Switzerland
|
-$190K |
| 2 |
Chas P. Smith & Associates (CPS)
Lakeland,
Florida
|
-$115K |
CURE Hedge Fund Activity: Q3 2013 in Review
4 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Healthcare Bull 3X ETF (CURE) for Q3 2013, worth a combined $3.97M — up 120% from $1.81M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CURE positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $1.04M. The largest seller was UBS, cutting an estimated $190K.
- 4 institutional investors held Direxion Daily Healthcare Bull 3X ETF (CURE) as of Q3 2013, up from 3 in Q2 2013.
- Funds reported $3.97M of Direxion Daily Healthcare Bull 3X ETF stock for Q3 2013, up 120% quarter-over-quarter.
- 1 fund opened new Direxion Daily Healthcare Bull 3X ETF positions in Q3 2013 and 0 closed out, a net change of +1 holder.
- The largest Direxion Daily Healthcare Bull 3X ETF buyer in Q3 2013 was Susquehanna International Group, an estimated $1.04M added.
- The largest Direxion Daily Healthcare Bull 3X ETF seller in Q3 2013 was UBS, an estimated $190K sold.
Based on aggregated 13F filings for Q3 2013.